Announcements
- Directors’ / PDMR Dealing and Grant of Options
- Results for the Year ended 31 December 2023
- Notice of Results and Investor Presentation
- Eroxon to be available on prescription
- Trading Update
- Appointment of Joint Corporate Broker
- Director/PDMR Dealing
- Remuneration of Non-Exec Directors & Voting Rights
- Futura Medical extends collaboration with Cooper
- Appointment of Roy Davis as Non-Executive Director
More ▼
Key statistics
On Wednesday, Futura Medical PLC (GYX:STU) closed at 0.44, 66.67% above the 52 week low of 0.264 set on Dec 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.432 |
---|---|
High | 0.44 |
Low | 0.432 |
Bid | 0.444 |
Offer | 0.478 |
Previous close | 0.436 |
Average volume | 0.00 |
---|---|
Shares outstanding | 301.45m |
Free float | 199.72m |
P/E (TTM) | -- |
Market cap | 116.43m GBP |
EPS (TTM) | -0.0219 GBP |
Data delayed at least 15 minutes, as of May 22 2024.
More ▼